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Ethnopharmacological  relevance:  Rhizophora  mangle,  the  red  mangrove,  has  long  been  known  as  a  tradi-
tional  antiulcer  medicine.  The  present  work  evaluated  the  mechanisms  of  action  involved  in the  anti-ulcer
properties  of  the  Rhizophora  mangle  bark  extracts.
Materials and  methods:  Gastroprotection  of  Rhizophora  mangle  was  evaluated  in rodent  experimental
models  (ethanol).  To  elucidate  the  mechanisms  of action  the  antisecretory  action  and  involvement  of
NO,  SH,  mucus  and  PGE2 were  evaluated.  The  acetic  acid-induced  gastric  ulcer  model,  Western  blotting
assay  (COX-1,  COX-2  and  EGF)  and  immunohistochemical  localization  of  HSP-70,  PCNA  and  COX-2  were
also  used  to evaluate  the  Rhizophora  mangle  healing  properties.
Results:  Results  showed  that  Rhizophora  mangle  bark  crude  extract  (CE),  as  well  as  ethyl  acetate  (EtOAc)
and  butanolic  fractions  (BuOH)  provided  signiﬁcant  gastroprotection  at all the  tested  doses.  Thereby,
the  following  protocols  were  performed  using  the  lowest  dose  capable  of  producing  the  most  effective
gastroprotection,  which  was  the  BuOH  0.5  mg/kg  (P  <  0.001).  Several  mechanisms  are  involved  in the
antiulcer  activity  of  Rhizophora  mangle,  such  as, participation  of NO,  SH  and  mucus.  The enhancement
of  PGE2 levels  and  the  upregulation  of  COX-2  and  EGF  seem  to  be  directly  linked  to the  antisecretory,
cytoprotective  and  healing  effects  of  BuOH.  HSP-70  and  PCNA  are  also  involved  in this  cicatrisation
process.  No sign  of  toxicity  was  observed  in this  study,  considering  the  analyzed  parameters.
Conclusion:  Our  study  reinforces  its traditional  medicinal  use.  Considering  that  the  current  therapies  are
based  on  the  use  of  antisecretory  or cytoprotective  drugs,  the  Rhizophora  mangle  arises  as  a promising
alternative  antiulcer  therapy.. Introduction
The stomach is constantly exposed to a wide range of sub-
tances that have the capacity to cause epithelial damage, such as
ydrochloric acid and digestive enzymes (Wallace, 2005). Under
ormal conditions, mucosal integrity is maintained by defense
echanisms, which include an epithelial “barrier”, mucus secre-
ion, bicarbonate, prostaglandins, nitric oxide, growth factors,
eat-shock proteins and continuous blood ﬂow. Mucosal injury
ay  occur when noxious factors “overwhelm” an intact mucosal
∗ Corresponding author. Tel.: +55 1935216192; fax: +55 1935216185.
E-mail address: defaria.felipe@yahoo.com.br (F.M. de-Faria).
378 8741- © 2011 Elsevier Ireland Ltd    . 
oi:10.1016/j.jep.2011.11.007
Open access under the Elsevier OA license.© 2011 Elsevier Ireland Ltd. 
defense or when the mucosal defense is somehow impaired (Laine
et al., 2008).
Proton pump inhibitors (i.e., lansoprazole) are the most potent
inhibitors of gastric acid secretion available; because of its efﬁcacy,
current guidelines recommend their use for the treatment of
acid-related gastric diseases (Sheen and Tridaﬁlopoulus, 2011).
Treatments of gastric disorders with medicinal plants are quite
common in traditional medicine worldwide (Schmeda-Hirschman
and Yesilada, 2005). The beneﬁcial effects of herbal and plant
extracts (isolated or in combination) in the prevention of gastric
injury have been evaluated in several experimental studies;
Open access under the Elsevier OA license.three main functions including antisecretory, cytoprotective
and antioxidant activities, isolated or in combination, are
responsible for gastric mucosal protection (Al Moﬂeh,
2010).
noph
a
a
s
P
s
e
d
d
w
t
2
2
i
(
o
e
C
s
p
2
U
t
T
a
l
t
p
U
C
e
2
l
P
t
e
S
s
w
y
(
i
o
a
t
i
w
f
f
t
3
2
(F.M. de-Faria et al. / Journal of Eth
Rhizophora mangle, the red mangrove, has long been known
s a traditional medicine, its bark has been used as astringent,
ntidysentery, anti-diarrheal, antihemorrhagic, antiseptic, hemo-
tatic, with antifungic and antiulcerogenic properties (Roig, 1988;
io-Corrêa, 1984). In recent years, various authors have described
ome activities such as antioxidant (Sánchez et al., 2006; de-Faria
t al., 2009), antiulcer (Perera et al., 2001; Berenger et al., 2006;
e-Faria et al., 2009) and wound healing (Fernández et al., 2002;
e Armas et al., 2005). Based on these data, we focused the present
ork on the mechanisms involved in the anti-ulcer properties of
he Rhizophora mangle bark extracts.
. Materials and methods
.1. Drugs and chemicals
The following drugs were used: lansoprazole (Medley, Camp-
nas, Brazil), acetic acid (Sinth, SP, Brazil), absolute ethanol
©Merk KGaA, Darmstadt, Germany); cimetidine, carbenox-
lone, indomethacin, L-NAME (N-G-nitro-l-arginine), NEM (N-
thylmaleimide), Alcian Blue and NaCl were from Sigma Chemical
o. (St. Louis, USA). The chemicals used in the buffers and other
olutions were all of analytical grade. All drugs and reagents were
repared immediately before use.
.2. Animals
Male Wistar rats Unib: WH (150–250 g) and male Swiss mice
nib: SW (25–35 g), both obtained from the breeding facility of
he State University of Campinas (CEMIB/UNICAMP), were used.
he animals were fed a certiﬁed Nuvilab® (Nuvital) diet with free
ccess to tap water under standard conditions of 12 h dark–12 h
ight, humidity (60 ± 1.0%) and temperature (21 ± 1%). Moreover,
he animals were kept in cages with raised ﬂoors of wide mesh to
revent coprophagy. The UNICAMP Institutional Animal Care and
se Committee, following the recommendations of the Canadian
ouncil on Animal Care (Olfert et al., 1993), approved all of the
mployed protocols.
.3. Plant material and preparation of the extracts
The barks of Rhizophora mangle L. (Rhizophoraceae) were col-
ected in “Estuário de Santos”, Santos, SP, Brazil. Professor M.Sc.
aulo Salles Penteado Sampaio authenticated the botanical iden-
ity of the plants and a voucher specimen (HUSC – P.S.P. Sampaio
t al., 800) was deposited at the “Herbário da Universidade
anta Cecília-HUSC”. The bark of Rhizophora mangle was  dried for
even days at 40 ◦C (213 g) and powdered (3 m).  The acetone:
ater (7:3) extract was prepared by maceration and obtained a
ield of 31.4% (66.9 g). The extract from Rhizophora mangle bark
CE) was submitted to liquid–liquid partition with solvents of
ncreasing polarity, thereby semi-puriﬁed fractions. This method-
logy provides a proper clean up of the polar extracts (Yunes
nd Calixto, 2001). Approximately 20 g of the extract was par-
itioned between 150 mL  of water and 50 mL of ethyl acetate
n a separation funnel for 3 times. Then, the aqueous phase
as also partitioned with 50 mL  of n-butanol (for 3 times). All
ractions were concentrated under vacuum to obtain the dried
ractions: aqueous fraction (Aq; 6.34 g, 31.7%), ethyl acetate frac-
ion (EtOAc; 4.82 g, 24.10%) and butanolic fraction (BuOH; 7.73 g,
8.65%)..4. Phytochemical
Chromatographic analyses of CE (10 L), Aq (10 L), EtOAc
10 L) and BuOH (10 L) were performed by TLC (Flukaarmacology 139 (2012) 234– 243 235
Si-gel plateson glass, 20 cm × 20 cm × 0.25 mm)  eluted with
CHCl3:MeOH:n-PrOH:H2O (5:6:1:4, v/v/v/v) in a previous com-
munication published by de-Faria et al. (2008).  Flavonoids were
detected by spraying the plates with natural products reagent and
polyethylene glycol (NP/PEG). Phenolic compounds are detected
after exposing the plates to ammonia vapors and immediate obser-
vation of ﬂuorescent spots under UV light. Total phenols were
detected with 5% ferric chloride solution in MeOH (Wagner et al.,
1984).
2.5. Acute toxicity
The acute toxicity studies were performed on male and female
Swiss mice (n = 10). A single dose of the extract was administered
orally to groups of animals after a 12-h fast. Animals receiving saline
0.9% served as control. The signs and symptoms associated with the
CE administration (5 g/kg, p.o.) were observed at 0, 30, 60, 120, 180
and 240 min  after and then once a day for the next 14 days. At
the end of the period, the number of survivors was  recorded and
the acute toxicological effect was estimated through the method
described by Souza-Brito (1994).
2.6. Gastroprotection activity
2.6.1. Ethanol-induced gastric ulcer
The rats were divided into six treatment groups, fasted 24 h
prior to receiving an oral dose of the vehicle (saline 10 mL/kg), lan-
soprazole (30 mg/kg), CE (50, 100, 250 and 500 mg/kg), Aq (6.25,
12.50, 25 and 50 mg/kg) and EtOAc and BuOH (0.5, 1.5, 3.0, 6.25,
12.5, 25 and 50 mg/kg). After 60 min, all groups were orally treated
with 1 mL  of absolute ethanol for the gastric ulcer induction. One
hour later, the animals were sacriﬁced and their stomachs excised
and gastric contents aspirated. Each stomach was  incised along the
greater curvature and examined for linear hemorrhagic lesions in
the glandular region (Morimoto et al., 1991). Then, the stomachs
were photographed and the extent of the lesions was measured
(mm2) by the program AVSoft BioView (Khan, 2004).
2.6.2. Role of endogenous nitric oxide (NO) and sulfhydril
compounds (SH)
Male rats were divided into 6 groups and pretreated (i.p.) with
saline, L-NAME (N-G-nitro-l-arginine, 70 mg/kg) an inhibitor of the
NO synthesis or NEM (N-ethylmaleimide, 10 mg/kg) a blocker of
SH compounds. Thirty minutes after the pretreatment, the ani-
mals were administered (p.o.) vehicle, carbenoxolone (100 mg/kg)
or BuOH (0.5 mg/kg). After 60 min, all the groups received absolute
ethanol (10 mL/kg) to induce gastric ulcers. One hour after receiv-
ing ethanol the rats were killed for the determination of the gastric
lesions (Arrieta et al., 2003).
2.6.3. Gastric acid secretion
The determination of gastric secretion was performed using the
method of Shay et al. (1945),  with a few modiﬁcations. The rats were
divided into groups (n = 7). After 24 h of fasting, the animals were
anesthetized, the abdomen was  incised and the pylorus ligated.
Immediately after the pylorus ligature, BuOH was administered at
a dose of 0.5 mg/kg, lansoprazole (30 mg/kg) was used as positive
control, and 1 mL  of vehicle (saline solution 0.9%) was  administered
as negative control. All the samples were administered intraduo-
denally. Four hours later, the animals were sacriﬁced by cervical
dislocation; the abdomen was opened, and another ligature placed
around the esophagus close to the diaphragm. The stomachs were
removed and the gastric content collected and drained into a grad-
uated centrifuge tube and centrifuged at 2000 × g for 15 min. The
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upernatant volume and pH were recorded with a digital pH meter
PA 200, Marconi S.A., Brazil).
.6.4. Determination of the mucus adhering to gastric wall
Rats were divided into groups (n = 7). After animals fasted for
4 h, BuOH (0.5 mg/kg), carbenoxolone (200 mg/kg) or the vehicle
as administered orally. Sixty minutes later, under anesthesia, the
bdomen was incised and the pylorus ligated. The animals were
illed 4 h after the surgery. The stomach content was  immersed in
0 mL  of 0.02% Alcian blue 0.16 M sucrose/0.05 M sodium acetate
olution, pH 5.8, and incubated for 24 h at 20 ◦C. The Alcian
lue binding extract was centrifuged at 2000 × g for 10 min. The
bsorbency of supernatant was measured by spectrophotometry at
98 nm.  The free mucus in the gastric content was  calculated from
he amount of Alcian blue binding the gastric mucus [mg/glandular
issue (g)]. This assay was performed according to the methodology
escribed by Corne et al. (1974).
.6.5. Determination of the PGE2 levels
Animals fasted for 24 h and divided randomly into the groups
ham, saline + indomethacin and BuOH + indomethacin. First, ani-
als were treated with saline or BuOH (p.o.), 30 min  after,
ndomethacin (dissolved in 5% sodium bicarbonate solution)
0 mg/kg was administered, s.c. Thirty minutes after indomethacin
dministration, the rats were killed, the stomachs removed,
eighed and then placed in 1 mL  of sodium phosphate buffer
10 mM,  pH 7.4). The tissue was ﬁnely minced and then incubated at
7 ◦C for 20 min. The prostaglandin E2 (PGE2) level was  quantiﬁed
ith an immune-enzymatic dosage kit from R&D Systems (USA).
he methodology was according to Curtis et al. (1995).
.7. Healing properties
.7.1. Acetic acid-induced gastric ulcer
Ulcer induction was based on Okabe and Amagase (2005).  Male
istar rats (n = 15) after fasting for 24 h, were used in this experi-
ent. Under anesthesia, laparotomy was performed on all animals
hrough a midline-epigastric incision. After exposing the stomach,
.05 mL  (v/v) of a 30% acetic acid solution was injected into the sub-
erosal layer in the glandular part of the anterior wall. The stomach
as bathed with saline to avoid adherence to the external surface of
he ulcerated region. The abdomen was then closed and the animals
ere fed normally.
The rats were divided into groups: saline (10 mL/kg, nega-
ive control), lansoprazole (30 mg/kg, positive control) and BuOH
0.5 mg/kg). The animals received the treatments by gavage once a
ay for 14 consecutive days, beginning 2 days after surgery. During
his period, body weight was recorded daily to evaluate possible
hronic toxicity induced by BuOH. Five animals of each group were
illed at days 4, 8 and 14 after the induction of the gastric lesions to
valuate de evolution of the cicatrisation, and then, the stomachs
ere removed. The gastric lesions were evaluated by examining
he inner gastric surface with a dissecting magnifying glass. The
tomachs were then photographed and the extent of the lesions
as measured (mm2) by the program AVSoft BioView (Khan, 2004).
he lesion was half-sectioned and one portion was  ﬁxed in ALFAC
olution (alcohol, acetic acid and formaldehyde) for 24 h at 4 ◦C; the
ther portion of the stomachs was stored at −80 ◦C for biochemical
nalysis. The samples were then routinely processed for embedding
n paraplast, cut into 10 m-thick sections and put onto histological
lides..7.1.1. Toxicity evaluation. The toxicological parameters were set
ccording to the method of Souza-Brito (1994).  We  evaluated the
oxicity in the animals submitted to BuOH treatment under the
forementioned cicatrisation model. For a period of 14 days, BuOHarmacology 139 (2012) 234– 243
effects were observed daily (body weight progression, hair and
mucosal alteration). The following organs were weighed to detect
any effect of the extract on their individual weights: heart, lungs,
liver, kidneys and spleen.
2.7.2. Expression of COX-1, COX-2 and EGF
Frozen glandular stomachs samples were homogenized in 1 mL
of ice cold buffer (PB 0.1 M,  pH 7.4 and protease inhibitor 1%).
Homogenates were centrifuged (12,000 × g, 15 min, 4 ◦C) and the
supernatants were collected and stored at −80 ◦C. Protein concen-
tration of the homogenate was  determined following Bradford’s
colorimetric method (1976).  Then, samples were treated with
Laemmili buffer (PB buffer 0.5 M,  pH 6.8; glycerol, sodium dode-
cyl sulfate (SDS) 10%, bromophenol 0.1%, -mercaptoethanol)
in a 1:1 proportion. Equal amounts of protein from samples
(100 g) were separated on 10% acrylamide gel by sodium dode-
cyl sulfate polyacrylamide gel electrophoresis. In the next step,
proteins were electrophoretically transferred onto a nitrocellu-
lose membrane and incubated with speciﬁc primary antibodies:
EGF (Santa Cruz Biotechnology, Inc., USA), COX-1 and COX-2 (Cay-
man Chemical, USA) at dilution of 1:500. Each membrane was
washed three times for 10 min  and incubated with anti-goat
immunoglobulin G antibody (Zymed Laboratories, USA) for EGF and
with anti-rabbit (Zymed Laboratories, USA) for COX-1 and COX-
2, all diluted at 1:5000. To prove equal loading, the blots were
analyzed for -actin expression using an anti--actin antibody
(Sigma–Aldrich, MO,  USA). Immunodetection was  performed using
enhanced chemiluminescence light-detecting kit (SuperSignal®
West Femto Chemiluminescent Substrate, Pierce, IL, USA). Densio-
metric data were performed following normalization to the control
(housekeeping gene) by AVSoft program.
2.8. Histological analysis
The slides were observed after haematoxylin and eosin (HE)
staining (Behmer et al., 1976). The slides also underwent Periodic
Acid Schiff (PAS) staining (Vacca, 1985), by which we observed
mucus production. Histological analyses were made using a Leica
microscope associated with Leica Q-Win Software 3.1 (Leica-
England), from the image analysis laboratory of the Department
of Morphology, UNESP-Botucatu.
2.8.1. Immunohistochemical localization of PCNA, HSP-70 and
COX-2
Representative slides of gastric tissue were deparafﬁnized, rehy-
drated and immunostained by the peroxidase anti-peroxidase
method. High temperature antigen unmasking technique was
employed in 0.01 M citrate buffer pH 6.0 in a microwave oven,
twice for 5 min  each, except for HSP-70. Blocking of nonspe-
ciﬁc reaction was performed with 3% non-fat milk, and sections
were incubated with primary antibodies for PCNA mouse mono-
clonal antibody (Novo Castra NCL-PCNA) (1:100), HSP-70 (Santa
Cruz Biotechnology SC-1060) (1:100), COX-2 (Cayman Chemical)
(1:200). After rinsing in phosphate buffered saline (0.01 mol/l PBS,
pH 7.4), the sections were incubated in secondary antiserum. They
were then washed in PBS and incubated in ABC (avidine and biotine
complex-Easy Path) and incubated in peroxidase reaction (3,3-
diaminobenzidine tetrahydrochloride) (Sigma) containing 0.01%
H2O2 in PBS buffer.2.9. Statistical analysis
Results were expressed as mean ± standard error of means
(S.E.M.). The statistical signiﬁcance of each test group in relation
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Table 1
Effect of CE, Aq, EtOAc and BuOH under the model of gastric ulcer induced by absolute ethanol. Ulceration lesion area (ULA) is presented as mean ± S.E.M. ANOVA followed
by  Dunnet’s t test.
Treatments (p.o.) Dose (mg/kg) n ULA (mm2) Inhibition (%)
Saline – 7 225.30 ± 35.00 –
Lansoprazole 30 7 51.13 ± 13.77*** 77.3
CE  500 7 0.00 ± 0.00*** 100
250  7 24.23 ± 12.51*** 89.2
100  7 3.62 ± 1.95*** 98.4
50  7 69.36 ± 16.63*** 69.1
Saline – 7 133.50 ± 19.04 –
Lansoprazole 30 7 35.31 ± 9.31** 73.5
Aq  50 7 104.50 ± 13.31 21.7
25  7 88.40 ± 27.11 33.7
12.5  7 23.94 ± 2.80*** 82.0
6.25  7 122.60 ± 26.12 8.1
Saline – 7 95.93 ± 9.72 –
Lansoprazole 30 7 16.43 ± 3.22*** 82.8
EtOAc 50 7 29.67 ± 8.07*** 69.0
25  7 33.27 ± 12.84*** 65.3
12.5  7 59.42 ± 3.60* 38.0
6.25  7 40.07 ± 8.30*** 58.2
3.0  7 37.30 ± 8.64*** 61.1
1.5  7 39.39 ± 4.93*** 58.9
0.5  7 58.67 ± 9.12* 38.8
BuOH 50 7 17.83 ± 4.68*** 81.4
25  7 28.03 ± 8.90*** 70.7
12.5  7 25.22 ± 5.56*** 73.7
6.25  7 49.93 ± 10.50** 47.9
3.0  7 57.39 ± 16.12* 40.1
1.5  7 52.26 ± 16.09* 45.5
0.5  7 18.30 ± 7.10*** 80.9
* P < 0.05 signiﬁcantly different from saline group.
**
t
T
3
3
o
t
f
n
A
a
T
E
TP < 0.01 signiﬁcantly different from saline group.
*** P < 0.001 signiﬁcantly different from saline group.
o the control was calculated using ANOVA followed by Dunnet or
ukey’s t test.
. Results
.1. Toxicity evaluation
CE was ﬁrst investigated for acute toxicity in mice. A single
ral dose of CE (5 g/kg) did not produce any visible signs or symp-
oms of toxicity in the treated animals. Since no acute toxicity was
ound using CE, we continued our studies evaluating the mecha-
isms underlying the anti-ulcer properties of Rhizophora mangle.
fter 14 days of administration of BuOH (0.5 mg/kg) in the acetic
cid-induced gastric ulcer model, no animal died and no signiﬁcant
able 2
ffect of oral BuOH treatment, under ethanol induced gastric ulcer, on animals pretreate
ukey’s  t test.
Pretreatments (i.p.) Treatments (p.o.) Dose (mg/kg) 
Saline Vehicle – 
Lansoprazole 30 
BuOH 0.5 
L-NAME Vehicle – 
Lansoprazole 30 
BuOH 0.5 
Saline Vehicle – 
Lansoprazole 30 
BuOH 0.5 
NEM  Vehicle – 
Lansoprazole 30 
BuOH 0.5 
* P < 0.05 signiﬁcantly different from saline group.
*** P < 0.001 signiﬁcantly different from saline group.macroscopic changes in daily body (Fig. 2A) or organ weights were
observed (data not shown).
3.2. Ethanol-induced gastric ulcer
In ethanol-induced gastric ulcer were tested all extracts
obtained from the bark of Rhizophora mangle, CE (50; 100; 250 and
500 mg/kg), Aq (6.25; 12.5; 25 and 50 mg/kg) EtOAc (0.5; 1.5; 3.0;
6.25; 12.5; 25 and 50 mg/kg) and BuOH (0.5; 1.5; 3.0; 6.25; 12.5;
25 and 50 mg/kg). This experimental model provides the screen-
ing of doses and efﬁcacy of the treatments against ulcer formation.
Results showed that CE as well as EtOAc and BuOH provided sig-
niﬁcantly gastroprotection in all tested doses (P < 0.05; 0.01 and
0.001), while Aq only produce protection at dose of 12.5 mg/kg
d with L-NAME or NEM. Data are presented as mean ± S.E.M. ANOVA followed by
n ULA (mm2) Inhibition (%)
7 176.60 ± 8.94 –
7 41.55 ± 10.91*** 76.4
7 56.01 ± 14.37*** 68.3
7 258.80 ± 22.83* –
7 61.18 ± 15.74*** 76.3
7 168.30 ± 23.31 35.0
7 195.80 ± 24.37 –
7 49.60 ± 11.64*** 74.6
7 71.15 ± 8.69*** 63.6
7 413.60 ± 29.47*** –
7 201.00 ± 19.01 51.4
7 251.50 ± 14.27 39.2
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dig. 1. Quantiﬁcation of adherent mucus (A) and PGE2 (B) in gastric mucosa of rats tr
ollowed by Dunnet’s t test, **P  < 0.01 and ***P < 0.001 signiﬁcantly different from n
P < 0.001) (Table 1). Thereby we focused the following protocols
sing the minor dose capable to produce the more effective gastro-
rotection, which was the BuOH 0.5 mg/kg (P < 0.001), furthermore,
lycosilated heterosides are the main constituents of BuOH, what
ontributes to an improved absorption, hence improving the bio-
ogical activity.
.3. Role of endogenous nitric oxide (NO) and sulfhydril
ompounds (SH)
As demonstrated by Table 2, the pretreatment with L-NAME or
EM led to the lost of the gastroprotection carried out by the BuOH
reatment, suggesting that NO and SH are required by the treatment
o provide its gastroprotection.
.4. Gastric acid secretion
The intraduodenal (i.d.) administration of BuOH signiﬁcantly
educed gastric juice volume (P < 0.05) and acidity (P < 0.05) while
ansoprazole reduced the acidity (P < 0.05).
.5. Determination of the mucus adhering to gastric wall and
GE2 levels
The treatment with BuOH augmented in more than 100% the
mount of mucus adhering to the gastric mucosa compared to con-
rol group (Fig. 1A), moreover, BuOH, concomitantly administered
ith indomethacin (a cyclooxygenase inhibitor) could enhance
he levels of PGE2 compared with control group which received
ndomethacin only (Fig. 1B).
ig. 2. Body weight in rats treated orally with vehicle (saline), lansoprazole and BuOH 
icatrisation on days 4, 8 and 14 of treatment (B). Results are presented as mean ± S.E.M. A
ifferent from saline. with BuOH from Rhizophora mangle. Results are presented as mean ± S.E.M. ANOVA
e control groups saline (A) or indomethacin (B).
3.6. Acetic acid-induced gastric ulcer
Chronic gastric ulcers were developed after 1 day of serosal
application. The gastric ulcer showed progressive healing in con-
trol (saline), lansoprazole (30 mg/kg) and BuOH (0.5 mg/kg) treated
groups of animals where ulcer area started reducing in size on day
4, a gradual decrease on day 8 and ﬁnal healing on day 14 in each
of the group. On day 4, lansoprazole (P < 0.05) and BuOH (P < 0.001)
already showed signiﬁcantly different from control group, BuOH
(P < 0.01) also showed difference from lansoprazole group. After
8 days of treatment, the healing remained delayed in control
group while the treatment with BuOH (P < 0.001) or lansoprazole
(P < 0.001) improved the cicatrisation; again, the difference of lan-
soprazole versus BuOH was  signiﬁcantly (P < 0.001). Fourteen days
after induction of lesions, both lansoprazole and BuOH were sig-
niﬁcantly different (P < 0.001) compared to control group (saline),
while statistical difference between lansoprazole and BuOH was
P < 0.01 (Fig. 2B).
3.7. Expression of COX-1, COX-2 and EGF
Western blotting analysis reveals that both COX-1 and COX-2
expression were found at the same values (P > 0.05) in all groups
on 4th and 8th days of treatment. On 14th day, COX-1 remains
unchanged. However, an upregulation of COX-2 and EGF expression
in lansoprazole (P < 0.05) and BuOH (P < 0.01) groups were found
when compared to control (saline).
3.8. Histological analysisHistological analysis was performed by the HE and PAS staining.
HE slices showed the architecture at the margin of the ulcer, even
lansoprazole (30 mg/kg) as well as BuOH (0.5 mg/kg) treatments
for 14 days after ulcer formation by acetic acid model (A). Evolution of the ulcer
NOVA followed by Tuckey’s t test, *P < 0.05, **P < 0.01 and ***P < 0.001 signiﬁcantly
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Fig. 3. Effects of oral administration during 4 days of BuOH on COX-1 and COX-2
expression in gastric mucosa of rats submitted to gastric ulcer induced by acetic acid.
D
g
s
s
a
m
i
a
3
C
w
a
a
t
a
i
4
m
b
p
c
m
t
m
p
(
Fig. 4. Effects of oral administration during 8 days of BuOH on COX-1 and COX-2
expression in gastric mucosa of rats submitted to gastric ulcer induced by acetic acid.ensitometry was  made following normalization with the control (housekeeping
ene). Data are expressed as mean ± S.E.M. ANOVA followed by Dunnet’s t test, no
tatistical differences were found.
howed gland preservation, and reduced granulation tissue. PAS
lso showed the preservation of inﬂamed tissue by the treatments,
oreover, PAS staining showed presence of gastric mucus and the
ntact disposition of the glands in the groups treated with BuOH
nd lansoprazole.
.9. Immunohistochemical localization of PCNA, HSP-70 and
OX-2
The gastric tissues obtained in the chronic model of gastric ulcer
ere used for immunohistochemical localization of PCNA, HSP-70
nd COX-2 antibodies. The analysis of histological slices showed
 great number of proliferation cells in the stomach of animals
reated with BuOH, the same proﬁle was found to HPS-70, as well
s COX-2. Thus, the results indicate that these proteins participated
n the healing of the gastric ulcer treated with BuOH for 14 days.
. Discussion
Various polyphenolic compounds, including tannins and other
etabolites (e.g., epigallocatechin gallate, procyanidins), have
een isolated from medicinal plants and their biological and
harmacological activities include anti-inﬂammatory, antise-
retory and antiulcerogenic effects. Crude extracts from some
edicinal tannin-rich plants are traditionally used worldwide toreat gastric ulcer (Okuda, 2005). Tannins are known to exist in
angrove species, which consist primarily of condensed tannins or
roanthocyanidins (Rahim et al., 2008). According to Sánchez et al.
1996) Rhizophora mangle bark extract present 80% of polyphenols,Densitometry was made following normalization with the control (housekeeping
gene). Data are expressed as mean ± S.E.M. ANOVA followed by Dunnet’s t test, no
statistical differences were found.
represented in their majority by condensed tannin (80%) and 20% of
hydrolysable tannin. Condensed tannins have attracted great atten-
tion due to rapid growing evidence associating these compounds
with a wide range of potential health beneﬁts (Zhang et al., 2010).
Ethanol-induced gastric ulcer models have been widely used
for the evaluation of gastroprotective activity, since basic informa-
tion can be provided by using it, as well as the determination of
the therapeutic dose. Thereby the gastroprotective effects of the
CE (50; 100; 250 and 500 mg/kg), Aq (6.25; 12.5; 25 and 50 mg/kg),
EtOAc (0.5; 1.5; 3.0; 6.25; 12.5; 25 and 50 mg/kg) and BuOH (0.5;
1.5; 3.0; 6.25; 12.5; 25 and 50 mg/kg) were veriﬁed (Fig. 1). Ethanol
is known to be one of many factors that increase the risk of gas-
tric ulcer formation. Hemorrhagic ulceration of the stomach in
humans and experimental animals is also caused by ingestion of
elevated amounts of ethanol. The main features of ethanol-induced
gastric ulcer are epithelial loss, mucosal edema and sub-epithelial
hemorrhage. Ethanol rapidly penetrates the gastric mucosa, its
injury is characterized by membrane damage, erosive hemorrhagic
lesions with diffuse coagulative cell necrosis, cell exfoliation, mul-
tiple superﬁcial erosions, marked vascular congestion and ulcer
formation (Gazzieri et al., 2007; Li et al., 2008; Nassini et al., 2010).
Rhizophora mangle antiulcer activity assessment was  ﬁrstly
performed with CE in ethanol-induced gastric lesions, once its
activity was  conﬁrmed, the study was carried out to evaluate
its organic fractions. The results obtained in the ethanol model
showed that CE as well as their Aq, EtOAc and BuOH fractions
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Fig. 5. Effects of oral administration during 14 days of BuOH on COX-1 and COX-
2  expression in gastric mucosa of rats submitted to gastric ulcer induced by acetic
acid. Densitometry was made following normalization with the control (housekeep-
ing gene). Data are expressed as mean ± S.E.M. ANOVA followed by Dunnet’s t test,
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Fig. 6. Effects of oral administration during 14 days of BuOH on EGF  expression in
gastric mucosa of rats submitted to gastric ulcer induced by acetic acid. Densitome-
the H+,K+-ATPase. Another possibility could be related to cytopro-
tective property, once we  found an interesting augmentation in
mucus and PGE2 levels by the BuOH administration (Fig. 1A and B,
respectively).
Table 3
Anti-secretory effect of intra-duodenal treatment with BuOH on rats submitted to
pylorus ligature model. Data are presented as mean ± S.E.M. ANOVA followed by
Dunnet’s t test.
Treatments
(i.d.)
Dose
(mg/kg)
n Gastric juice
volume (mL/4 h)
pH (units)
Saline – 7 1.78 ± 0.07 2.38 ± 0.05
Lansoprazole 30 7 1.51 ± 0.14 3.04 ± 0.23*P  < 0.05 and **P < 0.01 signiﬁcantly different from saline (control group).
ossess gastroprotective activity. Once all treatments had their
ctivity determined, we focused the succeeding experiments on
sing the most effective treatment with the lowest dose tested.
s demonstrated in the results (Fig. 1), the BuOH treatment
howed the most effective gastroprotection in the lowest dose used
0.5 mg/kg). Previous studies have already showed that tannins,
pecially condensed tannins, have pharmacological activity at low
oses (Iwasaki et al., 2004) and as it has been demonstrated by de-
aria et al. (2009) the antiulcer property of Rhizophora mangle at
ow doses is linked to an antioxidant property whereas the treat-
ent augmented the superoxide dismutase (SOD) activity against
schaemia/reperfusion-induced gastric ulcer.
In gastric ethanol injury, the endothelium is the ﬁrst preferential
arget for ethanol damage. Along with an increase in systemic blood
ressure, vasoconstriction of several vascular beds produced by the
ystemic administration of L-NAME, given to inhibit NO synthesis,
ould be certainly harmful, especially for gastric mucosa and its
ndothelium (Sikiric et al., 1997). As well as NO, the SH are impor-
ant for the maintenance of gastric mucosa because of its protection
gainst pro-oxidant agents, Luiz-Ferreira et al. (2010) reported
hat the administration of glutathione depletors (NEM) signiﬁ-
antly potentiate the effects of ethanol on gastric mucosa injury.
s presented in Table 2, the administration of L-NAME or NEM
ncreased the ulcer area in animals submitted to ethanol-induced
astric ulcer, the BuOH treatment completely loses its gastropro-
ection when L-NAME is co administered. Thus, our result suggeststry was made following normalization with the control (housekeeping gene). Data
are  expressed as mean ± S.E.M. ANOVA followed by Dunnet’s t test, *P < 0.05 and
**P < 0.01 signiﬁcantly different from saline (control group).
that BuOH gastroprotective effect depends on the participation of
mucosal sulfhydril compound levels and endogenous nitric oxide.
As aforementioned above, the antiulcer activity of BuOH sug-
gests the participation of antioxidant properties which are, well
known, linked to the maintenance of SH. On the other hand,
the relationship between BuOH gastroprotection and endogenous
NO could be explained based on the hypotension action of some
tannins and other ﬂavan-3-ol molecules, since this activity is a con-
sequence of endogenous stimulation of NO production by nitric
oxide synthase as related by Crestani et al. (2009).
Gastric acid has been known for many decades to be a key
factor in normal upper gastrointestinal functions, including pro-
tein digestion, calcium and iron absorption, as well as providing
some protection against bacterial infections. However, inappropri-
ate levels of gastric acid underlie several wide spread pathological
conditions, including gastric ulcer (Olbe et al., 2003). Proton pump
inhibitors (PPI) have an excellent safety proﬁle and have become
one of the most commonly prescribed class of drugs in primary
and specialty care. Their mechanism of action involves inhibition
of the H+,K+-ATPase enzyme that is present in gastric mucosal
parietal cells. PPIs are the most potent inhibitors of gastric acid
secretion available, with efﬁcacy superior to histamine-2 receptor
antagonists (Sheen and Tridaﬁlopoulus, 2011). Our results, Table 3,
showed the inhibitory effect of the administration of BuOH on gas-
tric juice and acid secretion. According to Murakami et al. (1992)
the antiulcer activity of tannins may  be related to its ability to
bind and precipitate proteins suggesting a directly inhibition ofBuOH 0.5 7 1.41 ± 0.06* 3.09 ± 0.09*
* P < 0.05 signiﬁcantly different from saline group.
F.M. de-Faria et al. / Journal of Ethnopharmacology 139 (2012) 234– 243 241
F ed gas
t -muco
g
s
g
t
e
s
h
d
t
b
m
T
s
g
h
m
s
e
a
c
s
s
(
P
o
t
h
p
u
m
t
t
b
t
m
Tig. 7. Histological slices of the stomachs from rats submitted to acetic acid induc
reatments, the legends found in HE image presented the gastric mucosa (m), sub
lands.
The term cytoprotection was described by Robert et al. (1979)
ince they noticed that prostaglandin was capable of suppressing
astric acid secretion, although they found out that doses far below
hose necessary for the antisecretory effect produced a protective
ffect against oral administration of necrotizing agents. Although
uppressors of acid secretion (e.g., H2 receptor antagonists, PPI)
ave been a mainstay for promotion of ulcer healing for three
ecades, there has been an increasing interest in recent years in
he mechanisms through which ulcers heal, and the possibility that
oth the speed and quality of healing may  be pharmacologically
odulated (Wallace, 2005).
Prostaglandins accelerate ulcer healing in experimental models.
he mechanisms responsible for this effect are not fully under-
tood, but the above-mentioned ability of prostaglandins to reduce
astric acid secretion would contribute to acceleration of ulcer
ealing (Wallace, 2008). In this context, the results obtained for
ucus and PGE2 levels are in agreement with the ﬁnding for anti-
ecretory activity of the BuOH, according to our ﬁndings. Alanko
t al. (1999) reported that phenolic compounds, such as tannins
nd ﬂavonols, have dual effect on prostaglandin biosynthesis; low
oncentrations stimulate and high concentrations inhibit. These
ubstances stimulate prostaglandin synthesis by reducing sub-
trates for the oxidized intermediates of prostaglandin H synthase
PGHS), thereby accelerating the peroxidase cycle and by protecting
GHC from self-catalyzed inactivation by removing the free radical
f PG.
It has been reported that PGE2 not only prevents the forma-
ion of irritant-induced gastric ulcer but also enhances gastric ulcer
ealing. For the effective treatment of gastric ulcers, not only the
revention of further ulcer formation, but also the enhancement of
lcer healing is important. The ability of prostaglandins to stimulate
ucus and bicarbonate secretion may  also signiﬁcantly contribute
o the promotion of ulcer healing. The endogenous prostaglandins
hat contribute to ulcer healing are mainly derived from COX-2, the
eneﬁcial effects of PGE2 on gastric ulcer healing in rodents appear
o be mediated via EP4 receptor (Wallace, 2008).
In order to evaluate the healing properties of the BuOH treat-
ent, acetic acid-induced gastric ulcer method was carried out.
his ulcer model highly resembles human ulcers in terms oftric ulcer assay. HE staining shows comparison of the tissue architecture between
sa (sm), muscular (mm) and glands (gl). PAS staining presented the mucus in the
pathological features and healing process (Okabe and Amagase,
2005). Animals were sacriﬁced 4, 8 and 14 days after the treatment
with saline, lansoprazole and BuOH as demonstrated by Fig. 2B.
The acceleration of healing in BuOH was  more effective than lan-
soprazole group in all days of evaluation. This could be explained
by the dual effect of BuOH; antisecretory and cytoprotective
properties. In this context, Okabe and Amagase (2005) showed
that anti-secretory drugs, prostaglandin analogs, mucosal defense
agents and various growth factors, all signiﬁcantly enhance healing
of acetic acid ulcers.
Hence, Western blotting analysis of COX-1 and COX-2 were per-
formed on days 4, 8 and 14 of treatment, while EGF expression and
histological evaluation were done on the 14th day. As can be seen in
Figs. 3 and 4, we  found no differences in COX-1 and COX-2 expres-
sion between the experimental groups on 4th and 8th days. On the
other hand, on the 14th day, an increase in COX-2 was  found for
lansoprazole and BuOH treatment. Tsuji et al. (2002) found that
lansoprazole increased the expression of COX-2 but not COX-1.
Our data are in agreement with their ﬁndings; the BuOH treat-
ment showed similar results on both COX-1 and COX-2 expression,
however its efﬁcacy was more signiﬁcant than presented by the
lansoprazole group.
While COX-1 is the predominant isoform expressed in the
healthy gastric mucosa, COX-2 expression can be upregulated very
rapidly. Substantial increased COX-2 expression can be seen fol-
lowing a mucosal exposure to a hapten, induction of ischemia or
when COX-1 activity is suppressed by aspirin. This upregulation of
COX-2 appears to be a defensive and anti-inﬂammatory response
aimed at enhancing mucosal defense (Wallace, 2008) (Fig. 5).
Healing requires angiogenesis in the granulation tissue at the
base of the ulcer, together with replication of epithelial cells at
the ulcer margins and subsequent re-establishment of glandular
architecture. Epithelial and endothelial cell proliferation is largely
driven by growth factors (Wallace, 2005). The major growth fac-
tor receptor expressed in gastric progenitor cells is the epidermal
growth factor receptor (EGF-R), EGF itself is absent in normal gas-
tric mucosa, however it is present in the gastric lumen, derived
from salivary and esophageal glands, and can stimulate progeni-
tor cell proliferation in case of injury (Laine et al., 2008). Takayama
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hemistry localization of PCNA, HSP-70 and COX-2.
t al. (2011) reported the participation of EGF in the process of heal-
ng of chronic gastric ulcers. We  also found an increase in the EGF
xpression (Fig. 6) of animals treated with lansoprazole or BuOH
or 14 days. In addition, histological analysis are in agreement with
he above ﬁndings, the HE and PAS staining (Fig. 7) showed the
aintenance of glands integrity by the BuOH treatment, which also
resented, by immunohistochemical localization, more presence
f proliferation cell natural antigen (PCNA), heat-shock protein-70
HSP-70) and COX-2 (Fig. 8).
As already mentioned, gastric ulcer healing is a process involv-
ng cell proliferation and migration at the gastric ulcer margin and
ngiogenesis in granulation tissue. When cells are exposed to gas-
ric irritants, expression of heat shock proteins is induced, making
he cells resistant to the irritants. Recently, Ishihara et al. (2011)
xamined the role of HSP-70 in gastric ulcer healing, providing the
vidence that HSP-70 accelerates the process of healing by increas-
ng the level of PGE2 and expression of growth factor, thereby
timulating cell proliferation at the gastric margin and angiogenesis
n granulation tissue. Immunohistochemical localization showed a
reat quantity of PCNA in the gastric mucosa of animals treated with
ansoprazole or BuOH. COX-2 immunolocalization just conﬁrmed
he Western blotting data.. Conclusion
Our study on the pharmacological mechanisms involved in the
ntiulcer activity of Rhizophora mangle reinforces its traditionalrazole (30 mg/kg) and BuOH (0.5 mg/kg) for 14 days. Images show immunohisto-
medicinal use. The treatment did not show any toxic effects, but
instead, demonstrated to have cytoprotective, antisecretory and
healing properties, possibly, due to the stimulation of PGE2 by the
upregulation of COX-2. Considering the current therapies are based
on the use of antisecretory or cytoprotective drugs, the Rhizophora
mangle arises as a promising alternative antiulcer therapy.
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